Franklin Andrew, Steele Edward J, Lindley Robyn A
Medical Department, Novartis Pharmaceuticals UK Limited, 200 Frimley Business Park, Frimley, Surrey, GU16 7SR, United Kingdom.
Melville Analytics Pty Ltd, Melbourne, Vic, 3004, Australia.
Heliyon. 2020 Feb 26;6(2):e03258. doi: 10.1016/j.heliyon.2020.e03258. eCollection 2020 Feb.
The mechanism of (CAG)n repeat generation, and related expandable repeat diseases in non-dividing cells, is currently understood in terms of a DNA template-based DNA repair synthesis process involving hairpin stabilized slippage, local error-prone repair via MutSβ (MSH2-MSH3) hairpin protective stabilization, then nascent strand extension by DNA polymerases-β and -δ. We advance a very similar slipped hairpin-stabilized model involving MSH2-MSH3 with two key differences: the copying template may also be the nascent pre-mRNA with the repair pathway being mediated by the Y-family error-prone enzymes DNA polymerase-η and DNA polymerase-κ acting as reverse transcriptases. We argue that both DNA-based and RNA-based mechanisms could well be activated in affected non-dividing brain cells . Here, we compare the advantages of the RNA/RT-based model proposed by us as an adjunct to previously proposed models. In brief, our model depends upon dysregulated innate and adaptive immunity cascades involving AID/APOBEC and ADAR deaminases that are known to be involved in normal locus-specific immunoglobulin somatic hypermutation, cancer progression and somatic mutations at many off-target non-immunoglobulin sites across the genome: we explain how these processes could also play an active role in repeat expansion diseases at RNA polymerase II-transcribed genes.
目前,关于(CAG)n重复序列的产生机制以及非分裂细胞中相关的可扩展重复序列疾病,是从基于DNA模板的DNA修复合成过程来理解的,该过程涉及发夹稳定的滑动、通过MutSβ(MSH2 - MSH3)发夹保护稳定进行的局部易错修复,然后由DNA聚合酶-β和-δ进行新生链延伸。我们提出了一个非常相似的涉及MSH2 - MSH3的滑动发夹稳定模型,但有两个关键区别:复制模板也可能是新生的前体mRNA,修复途径由作为逆转录酶的Y家族易错酶DNA聚合酶-η和DNA聚合酶-κ介导。我们认为基于DNA和基于RNA的机制在受影响的非分裂脑细胞中都可能被激活。在这里,我们比较了我们提出的基于RNA/RT的模型作为先前提出模型的补充所具有的优势。简而言之,我们的模型依赖于涉及AID/APOBEC和ADAR脱氨酶的先天和适应性免疫级联失调,这些脱氨酶已知参与正常的位点特异性免疫球蛋白体细胞超突变、癌症进展以及全基因组许多非靶向非免疫球蛋白位点的体细胞突变:我们解释了这些过程如何也能在RNA聚合酶II转录基因的重复扩增疾病中发挥积极作用。